Tumors of the Central Nervous System (Record no. 29241)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 01723nam a22002777a 4500 |
| 001 - CONTROL NUMBER | |
| control field | 20241021085741.0 |
| 003 - CONTROL NUMBER IDENTIFIER | |
| control field | OCoLC |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20241021090308.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 241021b |||||||| |||| 00| 0 eng d |
| 010 ## - LIBRARY OF CONGRESS CONTROL NUMBER | |
| LC control number | 2011923069 |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 978-94-007-0343-8 |
| International Standard Book Number | 978-94-007-0344-5 |
| 040 ## - CATALOGING SOURCE | |
| Transcribing agency | ddc |
| 041 ## - LANGUAGE CODE | |
| Language code of text/sound track or separate title | English |
| 082 ## - DEWEY DECIMAL CLASSIFICATION NUMBER | |
| Classification number | 616.994 HAY |
| 100 ## - MAIN ENTRY--PERSONAL NAME | |
| Fuller form of name | M.A. Hayat |
| 245 ## - TITLE STATEMENT | |
| Title | Tumors of the Central Nervous System |
| Remainder of title | Gliomas |
| Statement of responsibility, etc. | Glioblastoma (Part 1. |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Place of publication, distribution, etc. | London | |
| Name of publisher, distributor, etc. | Springer Science+Business Media B.V | |
| Date of publication, distribution, etc. | 2011 |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 456 Pages |
| Extent | Includes References and Index |
| 490 ## - SERIES STATEMENT | |
| Series statement | Tumors of the Central Nervous System |
| Volume/sequential designation | Volume 1 |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc. | The most recent developments in diagnostic and therapeutic aspects of Gliomas (Glioblastoma) in the brain are presented. The importance of personalized medicine and clinical validation for targeted therapy are discussed. The identification of various types of biomarkers is included. The identification and validation of brain cancer (glioblastoma) genes are discussed. Role of cancer stem cells in the initiation, progression, and persistence of malignant gliomas is explained. The use of surgical resection, chemotherapy (e.g., temozolomide), immunotherapy, and radiotherapy for malignant glioblastoma are pointed out. Standard (established) as well as newer imaging modalities (proton magnetic resonance spectroscopy) are discussed. |
| 600 ## - SUBJECT ADDED ENTRY--PERSONAL NAME | |
| General subdivision | Gliomas, Biochemical markers, Biomedicine, Central nervous system -- Tumors, Gliomas -- Diagnosis -- Treatment, Medical radiology, Medicine, Nervous system -- Surgery, Oncology, Pathology, Surgery |
| 856 ## - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="DOI 10.1007/978-94-007-0344-5 ">DOI 10.1007/978-94-007-0344-5 </a> |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) | |
| Source of classification or shelving scheme | ddc |
| Koha item type | E-BOOKS |
| Suppress in OPAC | |
| Withdrawn status | Lost status | Source of classification or shelving scheme | Damaged status | Not for loan | Home library | Current library | Date acquired | Total checkouts | Full call number | Barcode | Date last seen | Uniform resource identifier | Price effective from | Koha item type |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MWALIMU NYERERE LEARNING RESOURCES CENTRE-CUHAS BUGANDO | MWALIMU NYERERE LEARNING RESOURCES CENTRE-CUHAS BUGANDO | 10/21/2024 | 616.994 HAY | 20241021085741.0 | 10/21/2024 | DOI 10.1007/978-94-007-0344-5 | 10/21/2024 | E-BOOKS |